Health Trials

Relapsed and/or Refractory B-cell Lymphoma

1

Review clinical trials related to Relapsed and/or Refractory B-cell Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

The goal of this clinical study is to learn more about the safety and effectiveness of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma.

Participants needed: 247
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kite, A Gilead CompanyUpdated: Jun 29, 2026Locations: 26
Eligibility criteria

Relapsed and/or refractory B-cell lymphoma (R/R BCL). [+2]

History of malignancy other than nonmelanoma skin cancer or carcinoma in situ (e... [+11]

Read more